On-site Employee Flu Vaccination Program
On-site Flu Vaccinations & Flu Shots
As part of our health program, BizHealth provide on-site workplace flu vaccinations to employees across Australia.
We also provide our employee flu vaccinations in New Zealand.
In Australia, there is an average of 85 deaths and over 4,000 hospitalisations recorded due to influenza illness each year.
At BizHealth, we provide flu vaccinations to employees as part of our health program.
Influenza (the flu) is an acute viral illness, costing Australian businesses millions of dollars every year in absenteeism and sick leave. Initially affecting around 20% of staff, influenza’s highly contagious nature means it spreads rapidly. It also takes an average of two weeks to recover from, creating extreme productivity losses in the workplace. Calling a professional corporate health provider like BizHealth can help you avoid this harm to your business.
Immunisation is the single most effective action of preventing the spread of the flu in your workplace, with scientific research showing the flu vaccination reduces the risk by 70-90% in healthy people. This translates to a 43% reduction in absenteeism or 74 fewer lost days per 100 employees.
On-site Flu Vaccination Benefits
Reduce infection
Reduce the chances of infection and cross-infection from co-workers
Reduce absenteeism
Increase efficiency and keep employees safe in the workplace
Avoid productivity loss
Eliminate downtime and maximise productivity in the workplace
Influenza virus always mutates
The flu vaccination recommendations are updated regularly to keep up with new and changing strains
Commit to the wellbeing
Commit to the wellbeing of your individual workers
Create a healthy workplace
Keep your workplace as safe and healthy as possible for all employees
Risk of complications is higher if you suffer from a chronic condition
Cardiac disease
Diabetes
Respiratory disease
Chronic kidney disease
Impaired immunity
A chronic neurological disorder
Down syndrome
Obesity
What you need to know about flu vaccination
The Flu vaccine Contains the Flu virus
Flu vaccinations doesn’t contain any live virus, it is a mixture of protein and previous strains of influenza that are design to fight the dominant strain of influenza during each year recommended by the World Health Organisation (WHO). The Australian Influenza Vaccine Committee (AIVC) take in this recommendation and choose whether to implement or ignore these Vaccines to Australian residents.
Influenza Is Not that serious!
The flu virus is a highly contagious virus and it can be life threatening in some cases – it can cause an estimate of 1,500 deaths, 118,000 hospitalisations and 300,000 GP consultations annually in Australia. Although, many cases are deemed as non-threatening it is highly advised that an individual would seek medical advice in case of a more infectious virus strain.
The Flu vaccine Contains the Flu virus
Flu vaccinations doesn’t contain any live virus, it is a mixture of protein and previous strains of influenza that are design to fight the dominant strain of influenza during each year recommended by the World Health Organisation (WHO). The Australian Influenza Vaccine Committee (AIVC) take in this recommendation and choose whether to implement or ignore these Vaccines to Australian residents.
Influenza Is Not that serious!
The flu virus is a highly contagious virus and it can be life threatening in some cases – it can cause an estimate of 1,500 deaths, 118,000 hospitalisations and 300,000 GP consultations annually in Australia. Although, many cases are deemed as non-threatening it is highly advised that an individual would seek medical advice in case of a more infectious virus strain.
The Australian Influenza Vaccine Committee (AIVC) met on Wednesday 6th October 2021, to recommend the composition of the influenza virus vaccines for 2022. At this meeting, the expert committee reviewed and evaluated data related to epidemiology, antigenic and genetic characteristics of recent influenza isolates circulating in Australia and the Southern Hemisphere, serological responses to the 2020-2021 vaccines, and the availability of candidate vaccines viruses and reagents.
The committee recommended that the following viruses be included in quadrivalent influenza vaccines for the 2022 Southern Hemisphere influenza season:
an A/Victoria/2570/2019 (H1N1)pdm09-like virus;
an A/Darwin/9/2021 (H3N2)-like virus;
a B/Austria/1359417/2021-like (B/Victoria lineage) virus; and
a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.
an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
an A/Darwin/6/2021 (H3N2)-like virus;
a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
The composition of trivalent influenza vaccines is recommended to include the H1N1, H3N2 and the B Victoria lineage virus.
Sodium chloride
Dibasic sodium phosphate
Monobasic sodium phosphate
Potassium chloride
Monobasic potassium phosphate
Calcium chloride dihydrate
Water for injections
For full information on the influenza strains for 2022 visit: Consumer Medicine Information (PDF)https://www.tga.gov.au/aivc-recommendations-composition-influenza-vaccine-australia-2022
The Australian Influenza Vaccine Committee (AIVC) met on Wednesday 6th October 2021, to recommend the composition of the influenza virus vaccines for 2022. At this meeting, the expert committee reviewed and evaluated data related to epidemiology, antigenic and genetic characteristics of recent influenza isolates circulating in Australia and the Southern Hemisphere, serological responses to the 2020-2021 vaccines, and the availability of candidate vaccines viruses and reagents.
The committee recommended that the following viruses be included in quadrivalent influenza vaccines for the 2022 Southern Hemisphere influenza season:
an A/Victoria/2570/2019 (H1N1)pdm09-like virus;
an A/Darwin/9/2021 (H3N2)-like virus;
a B/Austria/1359417/2021-like (B/Victoria lineage) virus; and
a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.
an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
an A/Darwin/6/2021 (H3N2)-like virus;
a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
The composition of trivalent influenza vaccines is recommended to include the H1N1, H3N2 and the B Victoria lineage virus.
Sodium chloride
Dibasic sodium phosphate
Monobasic sodium phosphate
Potassium chloride
Monobasic potassium phosphate
Calcium chloride dihydrate
Water for injections
For full information on the influenza strains for 2022 visit: Consumer Medicine Information (PDF)https://www.tga.gov.au/aivc-recommendations-composition-influenza-vaccine-australia-2022
The Australian Influenza Vaccine Committee (AIVC) met on Wednesday 6th October 2021, to recommend the composition of the influenza virus vaccines for 2022. At this meeting, the expert committee reviewed and evaluated data related to epidemiology, antigenic and genetic characteristics of recent influenza isolates circulating in Australia and the Southern Hemisphere, serological responses to the 2020-2021 vaccines, and the availability of candidate vaccines viruses and reagents.
The committee recommended that the following viruses be included in quadrivalent influenza vaccines for the 2022 Southern Hemisphere influenza season:
a B/Austria/1359417/2021-like (B/Victoria lineage) virus; and
an A/Victoria/2570/2019 (H1N1)pdm09-like virus;
an A/Darwin/9/2021 (H3N2)-like virus;
a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.
an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
an A/Darwin/6/2021 (H3N2)-like virus;
a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
The composition of trivalent influenza vaccines is recommended to include the H1N1, H3N2 and the B Victoria lineage virus.
Sodium chloride
Dibasic sodium phosphate
Monobasic sodium phosphate
Potassium chloride
Monobasic potassium phosphate
Calcium chloride dihydrate
Water for injections
For full information on the influenza strains for 2022 visit: Consumer Medicine Information (PDF)https://www.tga.gov.au/aivc-recommendations-composition-influenza-vaccine-australia-2022
Ask our friendly team for a quick quote now!
Ask our friendly team for a quick quote now!